Mc Kinley Carter Wealth Services, Inc. Gilead Sciences, Inc. Transaction History
Mc Kinley Carter Wealth Services, Inc.
- $1.62 Billion
- Q3 2024
A detailed history of Mc Kinley Carter Wealth Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Kinley Carter Wealth Services, Inc. holds 3,127 shares of GILD stock, worth $295,220. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,127
Previous 3,134
0.22%
Holding current value
$295,220
Previous $215,000
21.86%
% of portfolio
0.02%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.9 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.23 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.83 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.68 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $118B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...